Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996-2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (3471) had both. All were sensitive to penicillin, ampicillin, cefazolin, cefotaxime, and vancomycin. Clindamycin and erythromycin resistance was 12.7% and 25.6%, respectively, and associated with serotype V (P
CITATION STYLE
Lynfield, R., Castor, M. L., Whitney, C. G., Como-Sabetti, K., Facklam, R. R., Ferrieri, P., … Schrag, S. J. (2008). Antibiotic resistance patterns in invasive group B streptococcal isolates. Infectious Diseases in Obstetrics and Gynecology. https://doi.org/10.1155/2008/727505
Mendeley helps you to discover research relevant for your work.